These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 19506123)
1. Predicting sudden death in the general population: another step, N terminal B-type natriuretic factor levels. Chugh SS; Reinier K Circulation; 2009 Jun; 119(22):2863-4. PubMed ID: 19506123 [No Abstract] [Full Text] [Related]
3. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients. Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of N-terminal pro-brain natriuretic peptide in sepsis. Tang BM; Huang SJ; Seppelt I; McLean AS Crit Care Med; 2007 Oct; 35(10):2464. PubMed ID: 17885399 [No Abstract] [Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction. Khan SQ; Quinn P; Davies JE; Ng LL Heart; 2008 Jan; 94(1):40-3. PubMed ID: 17488769 [TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide: a universal cardiac biomarker? Teodorovich N; Krakover R; Vered Z Isr Med Assoc J; 2008 Feb; 10(2):152-3. PubMed ID: 18432033 [No Abstract] [Full Text] [Related]
7. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
8. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of NH2-terminal pro B-type natriuretic peptide in patients with diabetes and stable coronary heart disease. Kragelund C; Gustafsson I; Omland T; Grønning B; Køber L; Faber J; Strande S; Steffensen R; Hildebrandt P Diabetes Care; 2006 Jun; 29(6):1411-3. PubMed ID: 16732036 [No Abstract] [Full Text] [Related]
10. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079 [TBL] [Abstract][Full Text] [Related]
11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure. Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053 [TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235 [TBL] [Abstract][Full Text] [Related]
13. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978 [TBL] [Abstract][Full Text] [Related]
14. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy. Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243 [TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)? Arora V; Bhandari S Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049 [No Abstract] [Full Text] [Related]
16. B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders. Godkar D; Bachu K; Dave B; Niranjan S; Khanna A Am J Ther; 2008; 15(2):150-6. PubMed ID: 18356635 [TBL] [Abstract][Full Text] [Related]